Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eli-Lilly
Company Monitoring Page for Eli-Lilly
latest headlines for company on cafepharma
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
Fierce Pharma
Sun, 06/14/20 - 08:14 pm
Tags:
ADA
,
diabetes
,
Eli Lilly
,
Trulicity
,
Novo Nordisk
,
Ozempic
Evox’s exosome platform draws Lilly in potential $1.2B CNS deal
BioWorld
Tue, 06/9/20 - 11:09 am
Tags:
Evox Therapeutics
,
Eli Lilly
,
exosomes
,
CNS
,
drug delivery
Lilly starts second COVID-19 antibody test with partner Junshi Biosciences, eyes combo trials
Fierce Biotech
Mon, 06/8/20 - 11:34 pm
Tags:
Eli Lilly
,
Junshi Biosciences
,
COVID-19
,
antibodies
FDA approval tracker: several early decisions in May
EP Vantage
Wed, 06/3/20 - 10:24 am
Tags:
FDA
,
Deciphera
,
Qinlock
,
Blueprint Medicines
,
Ayvakit
,
Eli Lilly
,
Retevmo
,
Bristol-Myers Squibb
,
Opdivo
,
Yervoy
Marketing Lilly's Cyramza, after split decision from FDA advisers, wins first-line lung cancer nod
Fierce Pharma
Mon, 06/1/20 - 11:34 pm
Tags:
Eli Lilly
,
Cyramza
,
FDA
,
non-small cell lung cancer
Eli Lilly's Taltz beats Novartis to the punch with FDA approval in spondyloarthritis
Fierce Pharma
Mon, 06/1/20 - 11:32 pm
Tags:
Eli Lilly
,
Taltz
,
Novartis
,
Cosentyx
,
axial spondyloarthritis
Eli Lilly begins first human tests of an antibody drug against Covid-19
Stat
Mon, 06/1/20 - 10:23 am
Tags:
Eli Lilly
,
COVID-19
,
antibodies
,
pandemic
,
clinical trials
Lilly wins first-ever FDA approval for drug that can spot Alzheimer's 'tau tangles'
BioPharma Dive
Fri, 05/29/20 - 12:17 pm
Tags:
Eli Lilly
,
FDA
,
Alzheimer's disease
,
R&D
,
tau tangles
,
Tauvid
,
imaging
,
diagnostics
The money keeps coming for Eli Lilly COVID-19 partner AbCellera with $105M round
Fierce Biotech
Wed, 05/27/20 - 10:55 am
Tags:
AbCellera
,
funding
,
COVID-19
,
Eli Lilly
A groundbreaking cancer drug nabs fast OK, giving Eli Lilly boasting rights as a rival speeds close behind
Endpoints
Sun, 05/10/20 - 09:30 pm
Tags:
Eli Lilly
,
selpercatinib
,
Retevmo
,
FDA
,
cancer
,
Loxo Oncology
,
Blueprint Medicines
COVID-19: Lilly ramps up to beat the virus with neutralizing antibodies as scientists raise worries
Fierce Biotech
Thu, 05/7/20 - 10:39 am
Tags:
Eli Lilly
,
Junshi Biosciences
,
antibodies
,
COVID-19
Eli Lilly, Junshi collaborate to develop antibody therapies for Covid-19 disease
Pharmaceutical Business Review
Tue, 05/5/20 - 10:42 am
Tags:
Eli Lilly
,
Junshi Biosciences
,
COVID-19
,
antibodies
,
R&D
Here’s how some big U.S. drugmakers expect Covid-19 to affect them this year
MedCity News
Mon, 05/4/20 - 10:37 pm
Tags:
COVID-19
,
pandemic
,
Gilead Sciences
,
Pfizer
,
Eli Lilly
,
JNJ
,
Merck
,
Amgen
The top pharma companies in social media
Fierce Pharma
Mon, 05/4/20 - 11:02 am
Tags:
social media
,
Boehringer Ingelheim
,
AbbVie
,
GSK
,
Pfizer
,
Novo Nordisk
,
Eli Lilly
,
Novartis
Lilly-partnered AbCellera gets COVID-19 boost from Canadian government
Fierce Biotech
Mon, 05/4/20 - 10:56 am
Tags:
Eli Lilly
,
AbCellera
,
Canada
,
COVID-19
,
antibodies
AbCellera and Lilly Slash Antibody Selection Time for COVID-19 With AI/Machine Learning
BioSpace
Tue, 04/28/20 - 11:43 pm
Tags:
AbCellera
,
Eli Lilly
,
antibodies
,
COVID-19
,
artificial intelligence
,
machine learning
AbbVie, Lilly and Gilead stay on top of pharma ad spending list for March amid steady overall spending
Fierce Pharma
Mon, 04/27/20 - 09:21 am
Tags:
AbbVie
,
Eli Lilly
,
Gilead Sciences
,
pharma advertising
,
DTC ads
,
television ads
,
pandemic
,
COVID-19
One COVID-19 opportunity for pharma? A chance to bolster its reputation, Lilly CEO says
Fierce Pharma
Thu, 04/23/20 - 09:27 pm
Tags:
Eli Lilly
,
Pharma CEOs
,
Dave Ricks
,
reputation
,
pharma industry
,
COVID-19
,
pandemic
Eli Lilly Reports First-Quarter Results, Adjusts Guidance
Motley Fool
Thu, 04/23/20 - 09:19 pm
Tags:
Eli Lilly
,
earnings
Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?
Fierce Biotech
Wed, 04/15/20 - 10:52 am
Tags:
COVID-19
,
pandemic
,
Merck
,
Januvia
,
diabetes
,
Boehringer Ingelheim
,
Eli Lilly
,
Tradjenta
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.